Skip to main content
Top
Published in: BMC Anesthesiology 1/2023

Open Access 01-12-2023 | Postoperative Nausea and Vomiting | Research

Remimazolam-remifentanil causes less postoperative nausea and vomiting than remimazolam-alfentanil during hysteroscopy: a single-centre randomized controlled trial

Authors: Xiaoqiang Zhang, Shuang Li, Jing Liu

Published in: BMC Anesthesiology | Issue 1/2023

Login to get access

Abstract

Background

Although the operation time of hysteroscopy is short, the incidence of postoperative nausea and vomiting is high. The aim of this study was to compare the incidence of postoperative nausea and vomiting in hysteroscopy when remimazolam is combined with remifentanil or alfentanil.

Methods

We conducted a randomized, controlled, double-blind trial. Patients undergoing hysteroscopy were recruited and randomly assigned to either the remimazolam-remifentanil (Group RR) or the remimazolam-alfentanil group (Group RA). All patients in the two groups were started with an induction dose of remimazolam besylate 0.2 mg/kg and then maintained with a dosage of 1.0 mg/kg/h. After induction with remimazolam besylate, in Group RR, remifentanil was infused using a target-controlled infusion system with a target concentration of 1.5 ng/ml and titrated throughout the procedure. In Group RA, infusion of alfentanil was started with an initial bolus dose of 20 µg/kg over 30 s and then maintained at an initial rate of 0.16 µg/kg/min. The primary observation outcome was the incidence rate of postoperative nausea and vomiting. The secondary observation outcomes were the time to awakening, the length of stay in the PACU, the total remimazolam dose and adverse effects, such as low SpO2, bradycardia, hypotension and body movement.

Results

A total of 204 patients were successfully included in this study. The incidence of postoperative nausea and vomiting in Group RR (2/102, 2.0%) was significantly lower than that in Group RA (12/102, 11.8%) (p < 0.05). There was no significant difference in the incidence of adverse events, such as low SpO2, bradycardia, hypotension and body movement, between Groups RR and RA (p > 0.05).

Conclusions

Remimazolam-remifentanil causes less postoperative nausea and vomiting than remimazolam-alfentanil in hysteroscopy.

Trial registration

Clinical trial registration number: ChiCTR2100044177. Full date of the first registration: 12/03/2021.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gupta AnilWuCL, Elkassabany Nabil, et al. Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery?: a systematic review of randomized controlled trials. [J] Anesthesiology. 2003;99:488–95.CrossRef Gupta AnilWuCL, Elkassabany Nabil, et al. Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery?: a systematic review of randomized controlled trials. [J] Anesthesiology. 2003;99:488–95.CrossRef
2.
go back to reference Duleba Antoni I-KN, Mrozikiewicz Aleksandra J, et al. Relationship of Postoperative Pain and PONV after minimally invasive surgery with the serotonin concentrations and receptors’ gene Polymorphisms[. J] J Pers Med. 2021;11:undefined. Duleba Antoni I-KN, Mrozikiewicz Aleksandra J, et al. Relationship of Postoperative Pain and PONV after minimally invasive surgery with the serotonin concentrations and receptors’ gene Polymorphisms[. J] J Pers Med. 2021;11:undefined.
3.
go back to reference Apfel CC, Läärä E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers.[J]. Anesthesiology. 1999;91(3):693–700.CrossRefPubMed Apfel CC, Läärä E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers.[J]. Anesthesiology. 1999;91(3):693–700.CrossRefPubMed
4.
go back to reference Moharram Ehab E, El Attar Ahmed M, Kamel Moustafa. A,the impact of anesthesia on hemodynamic and volume changes in operative hysteroscopy: a bioimpedance randomized study[. J] J Clin Anesth. 2017;38:59–67.CrossRefPubMed Moharram Ehab E, El Attar Ahmed M, Kamel Moustafa. A,the impact of anesthesia on hemodynamic and volume changes in operative hysteroscopy: a bioimpedance randomized study[. J] J Clin Anesth. 2017;38:59–67.CrossRefPubMed
5.
go back to reference Park Seongjoo,Choi Soo-Lyoen,Nahm Francis Sahngun. Dexmedetomidine-remifentanil vs propofol-remifentanil for monitored anesthesia care during hysteroscopy: Randomized, single-blind. controlled trial [J] Medicine (Baltimore). 2020;99:e22712.CrossRefPubMed Park Seongjoo,Choi Soo-Lyoen,Nahm Francis Sahngun. Dexmedetomidine-remifentanil vs propofol-remifentanil for monitored anesthesia care during hysteroscopy: Randomized, single-blind. controlled trial [J] Medicine (Baltimore). 2020;99:e22712.CrossRefPubMed
6.
go back to reference Mandel Jeff E. Considerations for the use of short-acting opioids in general anesthesia[. J] J Clin Anesth. 2014;26:1–7.CrossRef Mandel Jeff E. Considerations for the use of short-acting opioids in general anesthesia[. J] J Clin Anesth. 2014;26:1–7.CrossRef
7.
go back to reference Yi Fuxia,Xiao Hongyi,Zhu Teng. Prevention of postoperative nausea and vomiting after gynaecological day surgery under remimazolam general anesthesia: a randomized double-blind controlled study[. J] BMC Anesthesiol. 2022;22:292.CrossRef Yi Fuxia,Xiao Hongyi,Zhu Teng. Prevention of postoperative nausea and vomiting after gynaecological day surgery under remimazolam general anesthesia: a randomized double-blind controlled study[. J] BMC Anesthesiol. 2022;22:292.CrossRef
8.
go back to reference Dogru K, Madenoglu H,Yildiz K, et al. Sedation for outpatient endometrial biopsy: comparison of remifentanil-propofol and alfentanil-propofol[. J] J Int Med Res. 2003;31:31–5.CrossRefPubMed Dogru K, Madenoglu H,Yildiz K, et al. Sedation for outpatient endometrial biopsy: comparison of remifentanil-propofol and alfentanil-propofol[. J] J Int Med Res. 2003;31:31–5.CrossRefPubMed
9.
go back to reference Sneyd JR. Rigby-Jones Ann E,Remimazolam for anaesthesia or sedation. [J]. Curr Opin Anaesthesiol. 2020;33:506–11.CrossRefPubMed Sneyd JR. Rigby-Jones Ann E,Remimazolam for anaesthesia or sedation. [J]. Curr Opin Anaesthesiol. 2020;33:506–11.CrossRefPubMed
10.
go back to reference Zhang X, Li S, Liu J. Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial[J]. BMC Anesthesiol, 2021, 21(1). Zhang X, Li S, Liu J. Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial[J]. BMC Anesthesiol, 2021, 21(1).
11.
go back to reference Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer’s Assessment of Alertness/Sedation scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244–51.PubMed Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer’s Assessment of Alertness/Sedation scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244–51.PubMed
12.
go back to reference Chisholm Christopher J, Dmitry, et al. Comparison of electrophysiologic monitors with clinical assessment of level of sedation.[J]. Mayo Clin Proc. 2006;81:46–52.CrossRefPubMed Chisholm Christopher J, Dmitry, et al. Comparison of electrophysiologic monitors with clinical assessment of level of sedation.[J]. Mayo Clin Proc. 2006;81:46–52.CrossRefPubMed
13.
go back to reference Lee KH, Kim YH, Sung YJ, et al. The patient State Index is well balanced for propofol sedation[J]. Hippokratia. 2015;19(3):235–8.PubMedPubMedCentral Lee KH, Kim YH, Sung YJ, et al. The patient State Index is well balanced for propofol sedation[J]. Hippokratia. 2015;19(3):235–8.PubMedPubMedCentral
14.
go back to reference Sheng XY, Liang Y, Yang XY, Li LE, Ye X, Zhao X, et al. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy chinese volunteers. Eur J Clin Pharmacol. 2020;76:383–91.CrossRefPubMed Sheng XY, Liang Y, Yang XY, Li LE, Ye X, Zhao X, et al. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy chinese volunteers. Eur J Clin Pharmacol. 2020;76:383–91.CrossRefPubMed
16.
go back to reference Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997;86:10–23.CrossRefPubMed Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997;86:10–23.CrossRefPubMed
17.
go back to reference Hese LV, Theys T, Absalom AR, et al. Comparison of predicted and real propofol and remifentanil concentrations in plasma and brain tissue during target controlled infusion: a prospective observational study[J]. Anaesthesia; 2020. Hese LV, Theys T, Absalom AR, et al. Comparison of predicted and real propofol and remifentanil concentrations in plasma and brain tissue during target controlled infusion: a prospective observational study[J]. Anaesthesia; 2020.
18.
go back to reference Crozier TA, Kietzmann D, D?Bereiner. B. Mood change after anaesthesia with remifentanil or alfentanil[J]. European Journal of Anaesthesiology, 2004, 21(1):20. Crozier TA, Kietzmann D, D?Bereiner. B. Mood change after anaesthesia with remifentanil or alfentanil[J]. European Journal of Anaesthesiology, 2004, 21(1):20.
19.
go back to reference Caputo Thomas D, Ramsay Michael AE, Rossmann Jeffrey A, et al. Evaluation of the SEDline to improve the safety and efficiency of conscious sedation.[J].Proc. (Bayl Univ Med Cent). 2011;24:200–4. Caputo Thomas D, Ramsay Michael AE, Rossmann Jeffrey A, et al. Evaluation of the SEDline to improve the safety and efficiency of conscious sedation.[J].Proc. (Bayl Univ Med Cent). 2011;24:200–4.
20.
go back to reference Ye T, Yi Y. Sample size calculations in clinical research, third edition, by Shein-Chung Chow, Jun Shao, Hansheng Wang, and Yuliya Lokhnygina. Stat Theory Relat Fields. 2017;1:265–6.CrossRef Ye T, Yi Y. Sample size calculations in clinical research, third edition, by Shein-Chung Chow, Jun Shao, Hansheng Wang, and Yuliya Lokhnygina. Stat Theory Relat Fields. 2017;1:265–6.CrossRef
21.
go back to reference Schüttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132:636–51.CrossRefPubMed Schüttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132:636–51.CrossRefPubMed
22.
go back to reference Hari Yuki,Satomi Shiho,Murakami Chiaki. Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery[. J] J Anesth. 2022;36:265–9.CrossRefPubMed Hari Yuki,Satomi Shiho,Murakami Chiaki. Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery[. J] J Anesth. 2022;36:265–9.CrossRefPubMed
23.
go back to reference Ahn Eun Jin,Kang Hyun,Choi Geun Joo. The effectiveness of Midazolam for preventing postoperative nausea and vomiting: a systematic review and Meta-analysis. [J] Anesth Analg. 2016;122:664–76.CrossRef Ahn Eun Jin,Kang Hyun,Choi Geun Joo. The effectiveness of Midazolam for preventing postoperative nausea and vomiting: a systematic review and Meta-analysis. [J] Anesth Analg. 2016;122:664–76.CrossRef
24.
go back to reference Zhou Lijin,Yang Honghao,Hai Yong et al. Perioperative Low-Dose Ketamine for Postoperative Pain Management in Spine Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.[J].Pain Res Manag et al. 2022, 2022: 1507097. Zhou Lijin,Yang Honghao,Hai Yong et al. Perioperative Low-Dose Ketamine for Postoperative Pain Management in Spine Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.[J].Pain Res Manag et al. 2022, 2022: 1507097.
25.
go back to reference Beloeil Helene,Garot Matthias,Lebuffe Gilles. Balanced opioid-free anesthesia with Dexmedetomidine versus Balanced Anesthesia with Remifentanil for Major or. Intermediate Noncardiac Surgery [J] Anesthesiology. 2021;134:541–51.PubMed Beloeil Helene,Garot Matthias,Lebuffe Gilles. Balanced opioid-free anesthesia with Dexmedetomidine versus Balanced Anesthesia with Remifentanil for Major or. Intermediate Noncardiac Surgery [J] Anesthesiology. 2021;134:541–51.PubMed
26.
go back to reference Ozkose Z, Cok OY, Tuncer B et al. Comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anesthesia (TIVA)[J]. 2002, 14(3):0–168. Ozkose Z, Cok OY, Tuncer B et al. Comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anesthesia (TIVA)[J]. 2002, 14(3):0–168.
27.
go back to reference Langevin S, Lessard M R,Trépanier CA et al. Alfentanil causes less postoperative nausea and vomiting than equipotent doses of fentanyl or sufentanil in outpatients.[J].Anesthesiology, 1999, 91: 1666–73. Langevin S, Lessard M R,Trépanier CA et al. Alfentanil causes less postoperative nausea and vomiting than equipotent doses of fentanyl or sufentanil in outpatients.[J].Anesthesiology, 1999, 91: 1666–73.
28.
go back to reference Egan, Talmage D et al. Remifentanil Versus Alfentanil[J]. Anesthesiology, 1996. Egan, Talmage D et al. Remifentanil Versus Alfentanil[J]. Anesthesiology, 1996.
29.
go back to reference Wilhelm Wolfram,Kreuer Sascha,The place for short-acting opioids: special emphasis on remifentanil.[J].Crit Care, 2008, null: S5. Wilhelm Wolfram,Kreuer Sascha,The place for short-acting opioids: special emphasis on remifentanil.[J].Crit Care, 2008, null: S5.
30.
go back to reference Schulz Hapfelmeier Alexander HF, et al. A period of immobility after remifentanil administration protects from nausea: an experimental randomized cross-over study. [J] BMC Anesthesiol. 2016;16:90.CrossRefPubMedCentral Schulz Hapfelmeier Alexander HF, et al. A period of immobility after remifentanil administration protects from nausea: an experimental randomized cross-over study. [J] BMC Anesthesiol. 2016;16:90.CrossRefPubMedCentral
Metadata
Title
Remimazolam-remifentanil causes less postoperative nausea and vomiting than remimazolam-alfentanil during hysteroscopy: a single-centre randomized controlled trial
Authors
Xiaoqiang Zhang
Shuang Li
Jing Liu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2023
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-023-02164-3

Other articles of this Issue 1/2023

BMC Anesthesiology 1/2023 Go to the issue